Browsing Tag

Biotechs

DCGI clears Bharat Biotech’s Covaxin for restricted emergency use in children aged 6-12 years

Samir Sharma Apr 26, 2022

Bharat Biotech has been asked to submit safety data alongwith the data on adverse event with due analysis, every 15 days for the first two months and after that…
Read More...

Health

Bharat Biotech’s Covaxin’s phase three data shows 65.2% efficacy against Delta variant…

Samir Sharma Nov 12, 2021

The findings in the medical journal also revealed that the Indian-made vaccine showed 70.8% efficacy against all coronavirus variants…
Read More...

Health

SEC recommends DCGI to approve Bharat Biotech’s Covaxin for children between 2-18 years of…

Samir Sharma Oct 19, 2021

If approved, the two-dose vaccine will be given to children within 20 days apart.…
Read More...

Health

What WHO prequalification means for Bharat Biotech’s Rotavac 5D

Samir Sharma Aug 3, 2021

ROTAVAC 5D is a unique rotavirus vaccine formulation that can be administered without buffer Bharat Biotech on Monday…
Read More...

Health

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154- Technology…

Samir Sharma Aug 2, 2021

tech2 News StaffAug 02, 2021 08:07:43 ISTAfter releasing the results from Phase 2 human trials of its COVID-19 vaccine Covaxin in India, Bharat Biotech has now begun testing an…
Read More...

Health

Phase 3 clinical trial data shows Bharat Biotech’s Covaxin has 77.8 percent efficacy

Samir Sharma Jun 22, 2021

The data will be reviewed by the WHO on 23 June in a 'pre-submission meeting', and COVAXIN will be allowed for export to other countries only after an approval…
Read More...

Health

Explained: Why WHO’s emergency usage listing is important for Bharat Biotech’s COVAXIN-…

Samir Sharma Jun 8, 2021

tech2 News StaffJun 07, 2021 19:11:23 ISTIndian pharma company Bharat Biotech is still waiting to be added to the World Health Organisation's Emergency Use Listing (EUL). They had begun…
Read More...